Skip to main content
Back to OrbiMed

OrbiMed's Neuroscience Portfolio

Browse 6 Neuroscience companies funded by OrbiMed. See funding amounts, founder contacts, and investment details.

Neuroscience Companies
6
Total Funding in Neuroscience
$515.1M

Neuroscience Portfolio Companies (6)

Export
MedicalNeuroscienceTherapeutics

Leal Therapeutics develops novel therapeutics for patients.

Worcester, United States
August 2026
$30.0M
Series A

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeuroscienceTherapeutics

Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.

Cambridge, United States
June 2024
$40.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareMental HealthNeurosciencePharmaceutical

Helus Pharma is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

Toronto, Canada
June 2026
$50.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiotechnologyHealth CareLife ScienceNeurosciencePharmaceuticalTherapeutics

Aviceda Therapeutics is a late-stage pre-clinical biotech company developing drugs for treating glyco-immune diseases.

Cambridge, United States
January 2025
$207.5M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalNeurosciencePharmaceuticalTherapeutics

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies and autologous regenerative medicine.

San Diego, United States
November 2025
$115.0M
Series C

Founder Contacts

41,000+ verified contacts

Health CareMedicalMedical DeviceNeuroscience

Stairway Medical is a developer of implantable brain-computer interface technology.

Pudong, China
March 2026
$72.6M
Series Unknown

Founder Contacts

41,000+ verified contacts

Explore OrbiMed's Full Portfolio

View all companies funded by OrbiMed across every industry and funding stage.

View Full OrbiMed Portfolio